+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Minimal Invasive Spinal Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

  • PDF Icon


  • March 2022
  • Region: Global
  • GlobalData
  • ID: 5624957
Minimal Invasive Spinal Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Minimal Invasive Spinal (MIS) Devices market for the year 2020 and beyond. MIS devices can be used to treat a wide variety of orthopedic conditions that affect the spine, such as degenerative disc disease, spondylolisthesis, spinal stenosis, trauma, spinal tumors, and scoliosis. MIS surgeries are not very old procedures and have been introduced in the 1990's. Since the technology is new, the surgeries still are at naive stage and they have a long way to go in the future.

Unlike the traditional open spine surgeries, MIS surgeries are more technologically advanced and do not involve long incision. Specialized instruments and guided cameras are used to access the spine through small incisions. This prevents surrounding tissue damage and faster recovery.

MIS surgeries use Interbody Cages, Cannulated Screws, Rods and Non-Cannulated Screws to treat various conditions of the spine. Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

  • Currently marketed Minimal Invasive Spinal Device and evolving competitive landscape
  • Insightful review of the key industry trends.
  • Annualized total Minimal Invasive Spinal Device market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analysts' provide unique country specific insights on the market.
  • SWOT analysis for Minimal Invasive Spinal Device market.
  • Competitive dynamics insights and trends provided for Minimal Invasive Spinal Device market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system.

In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies Covered:

Medtronic plc, Johnson & Johnson, NuVasive Inc, Stryker Corp, Globus Medical Inc, Zimmer Biomet Holdings Inc and Others

Countries Covered:

United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.


This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
  • CMO executives who must have deep understanding of the Minimal Invasive Spinal Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:
  • Understand the impact of COVID-19 on Minimal Invasive Spinal Devices.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Minimal Invasive Spinal Devices.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Minimal Invasive Spinal Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Minimal Invasive Spinal Devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Johnson & Johnson
  • NuVasive Inc
  • Stryker Corp
  • Globus Medical Inc
  • Zimmer Biomet Holdings Inc